CAPITAL IMPACT ADVISORS, LLC – Eagle Pharmaceuticals, Inc. Transaction History
CAPITAL IMPACT ADVISORS, LLC portfolio value:
$465,000
portfolio value
CAPITAL IMPACT ADVISORS, LLC quarter portfolio value change:
-40.54%
quarter
Eagle Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +8.32% | 976 shares | -56K | $26.42 | 12.70K |
| Q2 2022 | share | Decrease | -26.32% | -4.19K shares | -267K | $44.43 | 11.72K |
| Q1 2022 | share | Decrease | -17.42% | -3.35K shares | -194K | $49.49 | 15.91K |
| Q4 2021 | share | 0.00% | 0 shares | -93K | $51.1 | 19.27K | |
| Q3 2021 | share | 0.00% | 0 shares | 250K | $55.78 | 19.27K | |
| Q2 2021 | share | Decrease | -46.18% | -16.53K shares | -670K | $42.8 | 19.27K |
| Q1 2021 | share | 0.00% | 0 shares | -173K | $41.74 | 35.81K | |
| Q4 2020 | share | 0.00% | 0 shares | 147K | $46.57 | 35.81K | |
| Q3 2020 | share | 0.00% | 0 shares | -197K | $42.48 | 35.81K | |
| Q2 2020 | share | 0.00% | 0 shares | 71K | $47.98 | 35.81K | |
| Q1 2020 | share | Increase | +6.20% | 2.09K shares | -379K | $46 | 35.81K |
| Q4 2019 | share | 0.00% | 0 shares | 123K | $60.08 | 33.72K | |
| Q3 2019 | share | Decrease | -4.05% | -1.42K shares | -30K | $56.57 | 33.72K |
| Q2 2019 | share | Increase | +3.57% | 1.21K shares | 602K | $55.68 | 35.14K |
| Q1 2019 | share | 0.00% | 0 shares | 0 | $50.49 | 33.93K | |
| Q4 2018 | share | Increase | +40.92% | 9.85K shares | -329K | $40.29 | 33.93K |
| Q3 2018 | share | 0.00% | 0 shares | -169K | $69.33 | 24.08K | |
| Q2 2018 | share | Decrease | -8.49% | -2.23K shares | 442K | $75.66 | 24.08K |
| Q1 2018 | share | Increase | 0.00% | 26.31K shares | 1.38M | $52.69 | 26.31K |